Drug Trial Radar · NCT05039450
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
Last checked: Nov 19, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
213
Actual
Start
Jul 30, 2021
Primary completion
Dec 15, 2023
Study completion Aug 28, 2025
Sponsor
- Lead sponsor
- Akero Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Sep 9, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in cirrhotic subjects with biopsy-proven F4 compensated NASH.
Conditions
- NASH - Nonalcoholic Steatohepatitis
Interventions
EFXDrug
Investigational drug, Efruxifermin
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Main: Change From Baseline in Fibrosis With no Worsening Steatohepatitis Assessed by NASH CRN SystemTime frame: Week 36
Locations
49 sites in 3 countries. Site status is shown where the registry gives one.
Akero Clinical Study Site
Chandler, Arizona
Akero Clinical Study Site
Glendale, Arizona
Akero Clinical Study Site
Tucson, Arizona
Akero Clinical Study Site
Tucson, Arizona
Akero Clinical Study Site
North Little Rock, Arkansas
Akero Clinical Study Site
Fresno, California
Akero Clinical Study Site
Long Beach, California
Akero Clinical Study Site
Los Angeles, California
Akero Clinical Study Site
Pasadena, California
Akero Clinical Study Site
Englewood, Colorado
Akero Clinical Study Site
Clearwater, Florida
Akero Clinical Study Site
Fort Myers, Florida
Akero Clinical Study Site
Fort Myers, Florida
Akero Clinical Study Site
Hialeah Gardens, Florida
Akero Clinical Study Site
Lakewood Rch, Florida
Akero Clinical Study Site
Miami Lakes, Florida
Akero Clinical Study Site
Ocala, Florida
Akero Clinical Study Site
Sarasota, Florida
Akero Clinical Study Site
South Bend, Indiana
Akero Clinical Study Site
Topeka, Kansas
Akero Clinical Study Site
Bastrop, Louisiana
Akero Clinical Study Site
Marrero, Louisiana
Akero Clinical Study Site
Las Vegas, Nevada
Akero Clinical Study Site
Concord, North Carolina
Akero Clinical Study Site
Fayetteville, North Carolina
Akero Clinical Study Site
Morehead City, North Carolina
Akero Clinical Study Site
Springboro, Ohio
Akero Clinical Study Site
Westlake, Ohio
Akero Clinical Study Site
Greenville, South Carolina
Akero Clinical Study Site
Greenwood, South Carolina
Akero Clinical Study Site
Summerville, South Carolina
Akero Clinical Study Site
Nashville, Tennessee
Akero Clinical Study Site
Austin, Texas
Akero Clinical Study Site
Dallas, Texas
Akero Clinical Study Site
Edinburg, Texas
Akero Clinical Study Site
Edinburg, Texas
Akero Clinical Study Site
Fort Worth, Texas
Akero Clinical Study Site
Fort Worth, Texas
Akero Clinical Study Site
Houston, Texas
Akero Clinical Study Site
Houston, Texas
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.